39 mins ago

Nuclear Medicine Gains Ground in Cancer Treatment Across India

Nuclear Medicine Gains Ground in Cancer Treatment Across India
When conventional therapies fail: Boost for nuclear medicine in cancer treatment - Telegraph India · telegraphindia.com

Nuclear medicine uses special medicines that can help doctors find or treat disease.

Specialists met in Calcutta to discuss how it can help people with cancer.

They talked about matching treatment more closely to what is happening inside a patient's body.

One approach, called theranostics, uses scans to help guide targeted treatment.

Some people with advanced prostate cancer are choosing PSMA therapy when other treatments do not work.

Radioactive iodine can be given after surgery to treat thyroid cancer.

Doctors also said PET-CT scans can add useful information to other scans.

Calcutta now has many more PET-CT machines than it did in 2010.

The specialists said there are still too few nuclear medicine doctors.

Key facts

Conference
24th edition of the Association of Nuclear Medicine Physicians of India Conference (ANMPICON)
Attendance
More than 200 nuclear medicine specialists from across India
Theranostics
Combines diagnostic imaging with targeted therapy
Prostate cancer
PSMA therapy is increasingly chosen for advanced cases when conventional treatment fails
Thyroid cancer
Radioactive iodine is used after surgery instead of conventional chemotherapy or radiotherapy, according to Deepanjan Mitra
PET-CT machines
Calcutta had hardly one in 2010; Deepanjan Mitra said the city now has as many as 30
Workforce concern
Physicians said nuclear medicine specialists are in short supply

Quotes

Soumendranath Ray

Organising chairperson of the conference.

“There is significant information that a CT or MRI provides, but there is certain adjunct or supplementary information that a PET-CT provides for more precise treatment planning, staging of the disease or evaluating the response to cancer treatment.”
telegraphindia.com
“We are moving beyond simply asking where the disease is. We are increasingly asking what the disease is at a molecular level and how we can use that knowledge to provide more precise and personalised treatment.”
telegraphindia.com

Sources

Related news